Tessera Therapeutics

Cambridge, MA · Founded 2018 · Privately Held (backing)

Developer of a gene writing technology designed to make permanent small and large alterations to the human genome. Tessera Therapeutics is based in Cambridge, MA and was founded in 2018. Its last reported valuation was $650 million in Dec 2024. It has raised $630 million.

Last reported valuation
$650.0M
Oct 2026
Priced at
—
Total raised
$630.0M
Last round
—

Who backs Tessera Therapeutics?

29 investors
InvestorType
SoftBank Investment AdvisersGrowth equity
University of CaliforniaOther
Gates FoundationOther
EDBIVenture capital
Qatar Investment AuthorityAsset manager
Catalio Capital ManagementVenture capital
T. Rowe Price Group—
TA VenturesVenture capital
Shake and BakeVenture capital
Foresite CapitalVenture capital
+ 19 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Tessera Therapeutics investors

29 investors are on record for Tessera Therapeutics, including SoftBank Investment Advisers, University of California, Gates Foundation and EDBI. By type, the record holds 11 venture capital firms and 1 growth equity firm.

Free account
More of Tessera Therapeutics with a free account
  • ·The complete investor list: 29 names
  • ·Watch Tessera Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 29 firms already write checks for companies like Tessera Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View